BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cai B, Hsu Y, Yeh F, Lin Y, Lu R, Yu S, Shaw J, Wu M, Tsai Y, Lin Y, Bai Z, Shih Y, Hsu Y, Liao R, Kuo W, Hsu C, Lien C, Chen C. P63 and P73 Activation in Cancers with p53 Mutation. Biomedicines 2022;10:1490. [DOI: 10.3390/biomedicines10071490] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Li Q, Tie Y, Alu A, Ma X, Shi H. Targeted therapy for head and neck cancer: signaling pathways and clinical studies. Signal Transduct Target Ther 2023;8:31. [PMID: 36646686 DOI: 10.1038/s41392-022-01297-0] [Reference Citation Analysis]
2 Tümen D, Heumann P, Gülow K, Demirci CN, Cosma LS, Müller M, Kandulski A. Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma. Biomedicines 2022;10. [PMID: 36551958 DOI: 10.3390/biomedicines10123202] [Reference Citation Analysis]
3 Rodriguez Calleja L, Lavaud M, Tesfaye R, Brounais-Le-Royer B, Baud'huin M, Georges S, Lamoureux F, Verrecchia F, Ory B. The p53 Family Members p63 and p73 Roles in the Metastatic Dissemination: Interactions with microRNAs and TGFβ Pathway. Cancers (Basel) 2022;14. [PMID: 36497429 DOI: 10.3390/cancers14235948] [Reference Citation Analysis]
4 Wu MH, Lu RY, Yu SJ, Tsai YZ, Lin YC, Bai ZY, Liao RY, Hsu YC, Chen CC, Cai BH. PTC124 Rescues Nonsense Mutation of Two Tumor Suppressor Genes NOTCH1 and FAT1 to Repress HNSCC Cell Proliferation. Biomedicines 2022;10. [PMID: 36428516 DOI: 10.3390/biomedicines10112948] [Reference Citation Analysis]
5 Zingarelli F, Zannoni L, Curti A. TP53 Mutant Acute Myeloid Leukemia: The Immune and Metabolic Perspective. Hemato 2022;3:742-757. [DOI: 10.3390/hemato3040050] [Reference Citation Analysis]